News headlines about Cutera (NASDAQ:CUTR) have trended somewhat positive on Sunday, Accern reports. Accern scores the sentiment of press coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Cutera earned a news impact score of 0.11 on Accern’s scale. Accern also assigned news headlines about the medical device company an impact score of 25 out of 100, meaning that recent press coverage is very unlikely to have an impact on the stock’s share price in the next few days.
These are some of the media headlines that may have effected Accern Sentiment’s analysis:
- Cutera Inc Stock in Q4 2016 Driven by Institutional Investors (thewestcoastsportsblog.com)
- Somewhat Favorable Media Coverage Very Unlikely to Impact Cutera (CUTR) Stock Price (lazeresportes.com)
- Cutera, Inc. (CUTR) Rating Reiterated by Sidoti (americanbankingnews.com)
- Mamou burglary ends in officer involved shooting, one dead (cote-ivoire.com)
- Karp Capital Management Corp Takes Position in Prospect Capital Corporation (PSEC) (latribunadecanarias.com)
Cutera (CUTR) traded up 2.28% during midday trading on Friday, hitting $26.95. The stock had a trading volume of 181,771 shares. The company has a market cap of $373.47 million, a PE ratio of 103.26 and a beta of 0.60. Cutera has a 52 week low of $10.43 and a 52 week high of $29.25. The stock’s 50 day moving average price is $23.01 and its 200-day moving average price is $20.36.
Cutera (NASDAQ:CUTR) last released its quarterly earnings data on Monday, May 1st. The medical device company reported ($0.07) earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of ($0.07). Cutera had a net margin of 2.89% and a return on equity of 9.21%. The firm had revenue of $29.30 million for the quarter, compared to the consensus estimate of $29 million. During the same quarter in the prior year, the company posted ($0.16) earnings per share. The business’s revenue was up 30.8% on a year-over-year basis. Equities research analysts predict that Cutera will post $0.46 earnings per share for the current year.
A number of research analysts have weighed in on the company. Zacks Investment Research lowered Cutera from a “hold” rating to a “sell” rating in a research note on Thursday, May 4th. TheStreet lowered Cutera from a “b-” rating to a “c” rating in a research report on Monday, May 1st. Sidoti reissued a “buy” rating and issued a $30.00 price objective (up from $27.00) on shares of Cutera in a research report on Saturday, June 3rd. Finally, Roth Capital started coverage on Cutera in a research report on Monday, June 26th. They issued a “buy” rating and a $32.00 price objective on the stock. Four research analysts have rated the stock with a buy rating, Cutera has an average rating of “Buy” and a consensus price target of $28.75.
TRADEMARK VIOLATION NOTICE: This report was reported by BBNS and is owned by of BBNS. If you are viewing this report on another site, it was copied illegally and republished in violation of United States and international copyright legislation. The legal version of this report can be viewed at https://baseballnewssource.com/markets/cutera-cutr-getting-somewhat-positive-press-coverage-alphaone-reports-updated-updated/1044077.html.
In other news, EVP Larry Laber sold 2,176 shares of the company’s stock in a transaction on Wednesday, April 19th. The shares were sold at an average price of $20.54, for a total value of $44,695.04. Following the completion of the sale, the executive vice president now owns 78,852 shares in the company, valued at approximately $1,619,620.08. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Ronald J. Santilli sold 60,991 shares of the company’s stock in a transaction on Monday, May 8th. The stock was sold at an average price of $19.99, for a total transaction of $1,219,210.09. Following the completion of the sale, the chief financial officer now owns 174,025 shares of the company’s stock, valued at approximately $3,478,759.75. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 165,410 shares of company stock worth $3,510,284. Corporate insiders own 11.60% of the company’s stock.
Cutera, Inc is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy-based aesthetics systems for practitioners across the world. The Company offers products based on product platforms, such as enlighten, excel HR, truSculpt, excel V and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures for customers.
Receive News & Ratings for Cutera Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera Inc. and related companies with our FREE daily email newsletter.